These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1376835)
1. Isradipine in the treatment of mild-to-moderate hypertension in Portugal. Pereira-Miguel JM; Correa-Nunes A; Rocha-Gonçalves F; Mariano-Pego G J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of isradipine in the treatment of mild-to-moderate hypertension in young and elderly patients. Batlouni M; Armaganijan D; Ghorayeb N; Magliano MF J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S53-7. PubMed ID: 1376836 [TBL] [Abstract][Full Text] [Related]
3. First clinical experience with isradipine in the treatment of hypertension in Portugal. Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485 [TBL] [Abstract][Full Text] [Related]
4. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study. Hermans L; Bogaert M; Degaute JP; Rorive G; Six R; Bara L; Lanssiers P; De Keyser P; Westelinck KJ J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S38-45. PubMed ID: 1376833 [TBL] [Abstract][Full Text] [Related]
5. [Clinical trial with isradipine in the treatment of mild and moderate arterial hypertension]. Miguel JM; Nunes AC; Gonçalves FR; Pêgo GM Rev Port Cardiol; 1991 Dec; 10(12):931-9. PubMed ID: 1839656 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension. Fitscha P; Meisner W; Hitzenberger G J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004 [TBL] [Abstract][Full Text] [Related]
8. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
9. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society. Lüscher TF; Waeber B J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension. Kirch W; Burger KJ; Weidinger G; Welzel D J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304 [TBL] [Abstract][Full Text] [Related]
11. Clinical studies on isradipine in the management of adult hypertensive patients at Moi University Teaching Hospital, Eldoret, Kenya. Lore W; Anjichi GM East Afr Med J; 1992 Feb; 69(2):69-73. PubMed ID: 1387077 [TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine. Welzel D; Burger KJ; Weidinger G J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308 [TBL] [Abstract][Full Text] [Related]
13. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
14. Long-term (2-year) isradipine data in the treatment of mild-to-moderate hypertension. D'Hont G; Meurant JP; Clement DL; Rorive G; Hermans L; De Keyser P; Westelinck KJ J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S46-8. PubMed ID: 1376834 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225 [TBL] [Abstract][Full Text] [Related]
16. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension. Meriç M; Gören T; Atilgan D; Eren N; Cubukçu A; Koylan N J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S58-60. PubMed ID: 1376837 [TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group. J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002 [TBL] [Abstract][Full Text] [Related]
18. The antihypertensive action of isradipine in mild essential hypertension. Viskoper JR; Laszt A; Farragi D J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488 [TBL] [Abstract][Full Text] [Related]
19. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737 [TBL] [Abstract][Full Text] [Related]
20. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol. Cantor A; Cristal N J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]